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We previously reported that a Kozak sequence variant in
the metabotropic glutamate receptor 3 gene (GRM3),
rs148754219, is associated with bipolar disorder (BP) and
affects gene transcription and translation (Kandaswamy
et al., 2013). A marker near GRM3, rs12704290, is one of
the top hits and reached genome-wide significance in a
recently reported genome-wide association study of
schizophrenia (SZ) (Ripke et al., 2014), and markers for
GRM3 have also been reported to demonstrate associa-
tion with alcohol dependence syndrome (ADS) (Levey
et al., 2014). In our original sample, considering patients
successfully genotyped for rs148754219, 19 out of 1062
BP cases and only four out of 932 controls were hetero-
zygous [odds ratio (OR)= 4.2 (1.4–12.3), P= 0.005]. We
have genotyped this variant in additional controls and
cases diagnosed with BP, SZ and ADS with the same
ancestry. Patients were assessed by trained clinicians as
described previously (Kandaswamy et al., 2013; Way et al.,
2014). Allele counts were compared and significance was
tested using Fisher’s exact test. Thirteen out of 934
additional BP cases and three out of 377 additional con-
trols were heterozygous [OR= 1.8 (0.49–6.2), P=not
significant]. Combined with the originally reported
results (Kandaswamy et al., 2013), 32 out of 1964 BP cases
and seven out of 1309 controls were heterozygous
[OR= 3.0 (1.3–6.8), P= 0.003]. Out of 1235 SZ cases 16
were heterozygous and were compared with the total
control sample [OR= 2.4 (0.99–5.8), P= 0.03]. Out of
1514 ADS cases 18 were heterozygous and one was
homozygous for the variant allele [OR= 2.5 (1.0–5.9),
P= 0.03]. If all case cohorts (BP, SZ and ADS) are com-
bined together, there would be one homozygote and 66
heterozygotes out of 4971 cases compared with the seven
heterozygotes out of 1309 controls [OR= 2.7 (1.2–5.8),
P= 0.004]. Previous work has supported the view that
some genetic risk factors may be common to different
psychiatric diagnoses (Lydall et al., 2011; Lee et al., 2013).
Although the individual results are of questionable sig-
nificance, the magnitude and direction of effect are
consistent across all the cohorts and thus suggest the
possibility that this rare variant may have a direct, func-
tional effect on the risk of developing any of these three
disorders. Because of its rarity, large sample sizes would
be needed to confirm these results. Doing this would be
worthwhile because if this finding is confirmed it could
provide molecular insight into a mechanism involving
GRM3 leading to increased risk of mental disorders and
could provide a basis for further functional and thera-
peutic studies.
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